Cargando…

Identification and Validation of a Potential Prognostic 7-lncRNA Signature for Predicting Survival in Patients with Multiple Myeloma

BACKGROUND: An increasing number of studies have indicated that the abnormal expression of certain long noncoding RNAs (lncRNAs) is linked to the overall survival (OS) of patients with myeloma. METHODS: Gene expression data of myeloma patients were downloaded from the Gene Expression Omnibus (GEO) d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Yun, Liu, Zhe, Li, Dangchi, Liao, Qinyuan, Li, Jingao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661128/ https://www.ncbi.nlm.nih.gov/pubmed/33204693 http://dx.doi.org/10.1155/2020/3813546

Ejemplares similares

Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma
por: Zhou, Meng, et al.
Publicado: (2015)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification and validation of stemness-related lncRNA prognostic signature for breast cancer
por: Li, Xiaoying, et al.
Publicado: (2020)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Aberrant lncRNA Expression in Multiple Myeloma
por: Meng, Hui, et al.
Publicado: (2018)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Development and internal validation of a nine-lncRNA prognostic signature for prediction of overall survival in colorectal cancer patients
por: Zhang, Zhiqiao, et al.
Publicado: (2018)

Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia
por: Liu, Chun-yu, et al.
Publicado: (2021)

Identification and Validation of 7-lncRNA Signature of Epigenetic Disorders by Comprehensive Epigenetic Analysis
por: Cao, Peng, et al.
Publicado: (2022)

Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma
por: Li, Jian, et al.
Publicado: (2023)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Identification of prognostic immune-related lncRNA signature predicting the overall survival for colorectal cancer
por: Li, Jianxin, et al.
Publicado: (2023)

Identification and validation of a five-lncRNA signature for predicting survival with targeted drug candidates in ovarian cancer
por: Lin, Nuan, et al.
Publicado: (2021)

Assessment of prognostic role of a novel 7-lncRNA signature in HCC patients
por: Qu, Junchi, et al.
Publicado: (2023)

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Systematic discrimination of the repetitive genome in proximity of ferroptosis genes and a novel prognostic signature correlating with the oncogenic lncRNA CRNDE in multiple myeloma
por: Qin, Jiading, et al.
Publicado: (2022)

Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma
por: Peng, Yue-Ling, et al.
Publicado: (2023)

Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer
por: Wu, Zhiwei, et al.
Publicado: (2022)

Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer
por: Zhang, Ruyue, et al.
Publicado: (2021)

A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma
por: Bao, Zhenyu, et al.
Publicado: (2017)

Comprehensive analyses of correlation and survival reveal informative lncRNA prognostic signatures in colon cancer
por: Gao, Meihong, et al.
Publicado: (2021)

Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma
por: Zhou, Chenghui, et al.
Publicado: (2021)

Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma
por: Ren, Jie, et al.
Publicado: (2021)

Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma
por: Wang, Jian, et al.
Publicado: (2021)

Discovery and Validation of a Novel Metastasis-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Tang, Qiang, et al.
Publicado: (2022)

Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma
por: Huang, Liang, et al.
Publicado: (2022)

Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer
por: Zhao, Bin, et al.
Publicado: (2023)

A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020)

Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer
por: Ma, Ensi, et al.
Publicado: (2021)

Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma
por: Liu, Xiao-Ping, et al.
Publicado: (2019)

Construction of a prognostic glycolysis‐related lncRNA signature for patients with colorectal cancer
por: Zhong, Xinyang, et al.
Publicado: (2022)

Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer
por: Xu, Minxian, et al.
Publicado: (2022)

Novel three-lncRNA signature predicts survival in patients with pancreatic cancer
por: Wu, Bin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_join8kdg16rcihe51k4l4p9oh3